A flexible electronic strain sensor for the real-time monitoring of tumor regression

Abstract

AbstractAssessing the efficacy of cancer therapeutics in mouse models is a critical step in treatment development. However, low resolution measurement tools and small sample sizes make determining drug efficacy in vivo a difficult and time-intensive task. Here we present a commercially scalable wearable electronic sensor that automates the in vivo testing of cancer therapeutics by continuously monitoring micrometer-scale tumor volume progression or regression in real-time. Histology, caliper measurements, and bioluminescence imaging over a one-week treatment period validated the sensor’s recordings, but the sensor’s higher time and length scale resolutions provided the only measurement technique capable of continuously monitoring the immediate hour-scale pharmacodynamic response of a given drug. In mice with two subcutaneously implanted tumor models our sensors recorded significant volume reductions in tumors just 5 hours after small molecule or immunotherapy treatment initiation. We anticipate that real-time tumor regression datasets could help expedite and automate the process of screening cancer therapies in vivo.